title: Worse patient VAS occurs at weeks 7 and 8 after infliximab infusions.
authors.forename: N
authors.initials: N
authors.lastname: Shenker
authors.forename: R
authors.initials: R
authors.lastname: Haigh
authors.forename: A
authors.initials: A
authors.lastname: Clarke
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006304:Health Status; D006801:Humans; D000069285:Infliximab; D017060:Patient Satisfaction; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab